Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 1,190 | 1,770 | 2,360 | 3,570 | 2,220 |
| Cost of Goods | 535 | 960 | 1,270 | 1,910 | 1,060 |
| Gross Profit | 654 | 810 | 1,090 | 1,660 | 975 |
| Operating Expenses | 4,060 | 2,910 | 940 | 2,200 | 550 |
| Operating Income | -2,870 | -1,140 | 420 | 370 | 670 |
| Interest Expense | 58 | 30 | 25 | 67 | 5 |
| Other Income | 156 | 0 | -1,664 | -1,893 | -1,505 |
| Pre-tax Income | -2,772 | -1,170 | -1,268 | -1,590 | -840 |
| Net Income Continuous | -2,772 | -1,176 | -1,268 | -1,590 | -840 |
| Net Income | $-2,772 | $-1,170 | $-1,260 | $-1,580 | $-840 |
| EPS Basic Total Ops | -3.92 | -0.42 | -0.56 | -0.70 | -9.10 |
| EPS Basic Continuous Ops | -3.91 | -0.49 | -0.53 | -0.67 | -9.10 |
| EPS Diluted Total Ops | -3.92 | -0.42 | -0.56 | -0.70 | -9.10 |
| EPS Diluted Continuous Ops | -3.91 | -0.49 | -0.53 | -0.67 | -9.10 |
| EBITDA(a) | $-2,604 | $-860 | $760 | $790 | $900 |